| Entry |
|
|---|
| Name |
Clavulanate potassium (JP18/USP);
CVA |
|---|
| Formula |
C8H8NO5. K
|
|---|
| Exact mass |
237.004
|
|---|
| Mol weight |
237.2511
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
|
|---|
| Remark |
| Product (mixture): | D06485<JP/US> |
|
|---|
| Efficacy |
Antibacterial, Cell wall biosynthesis inhibitor, beta-Lactamase inhibitor |
|---|
| Target |
beta-lactamases |
|---|
| Structure map |
|
|---|
| Brite |
Drug groups [BR:br08330]
Antibacterial
DG01710 beta-Lactam antibiotic
DG01713 Penicillin skeleton group
DG01487 Clavam
DG01261 Clavulanic acid
D02370 Clavulanate potassium
DG01479 beta-Lactamase inhibitor
DG01261 Clavulanic acid
D02370 Clavulanate potassium
Antimicrobials [BR:br08307]
Antibacterials
Cell wall biosynthesis inhibitor, beta-lactam
Beta-lactamase inhibitor
D02370 Clavulanate potassium (JP18/USP)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D02370 Potassium clavulanate
Drug groups [BR:br08330]
Antibacterial
DG01710 beta-Lactam antibiotic
DG01713 Penicillin skeleton group
DG01487 Clavam
DG01261 Clavulanic acid
DG01479 beta-Lactamase inhibitor
DG01261 Clavulanic acid
Antimicrobials abbreviations [BR:br08327]
Antibacterials
Cell wall biosynthesis inhibitor, beta-lactam
Beta-lactamase inhibitor
DG01261 Clavulanic acid
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 15
1 C1x C 12.7849 -10.4559
2 C5x C 12.7849 -11.8603
3 N1y N 14.1893 -11.8603
4 C1y C 14.1893 -10.4559
5 C1y C 15.5234 -12.2815
6 C2y C 16.3659 -11.1580
7 O2x O 15.5234 -10.0345
8 C6a C 16.0149 -13.6156
9 O6a O 17.4192 -13.6156 #-
10 O6a O 15.1722 -14.7390
11 O5x O 11.5912 -12.5624
12 C2b C 17.7659 -11.1580
13 C1b C 18.4814 -9.9184
14 O1a O 19.8798 -9.9183
15 Z K 18.9700 -13.6500 #+
BOND 15
1 1 2 1
2 2 3 1
3 3 4 1
4 1 4 1
5 3 5 1
6 5 6 1
7 6 7 1
8 4 7 1
9 5 8 1 #Down
10 8 9 1
11 8 10 2
12 2 11 2
13 6 12 2
14 12 13 1
15 13 14 1
|
|---|
